# The Changes of CD8+T Cells Frequency and Function During Antiviral Therapy

> **NCT03209037** · PHASE4 · UNKNOWN · sponsor: **Beijing Ditan Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Hepatitis B Infection

## Interventions

- **DRUG:** Peginterferon Alfa-2a

## Key facts

- **NCT ID:** NCT03209037
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03209037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03209037, "The Changes of CD8+T Cells Frequency and Function During Antiviral Therapy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03209037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*